Literature DB >> 21388888

Antigen-specific IgA B memory cell responses to Shigella antigens elicited in volunteers immunized with live attenuated Shigella flexneri 2a oral vaccine candidates.

J K Simon1, M Maciel, E D Weld, R Wahid, M F Pasetti, W L Picking, K L Kotloff, M M Levine, M B Sztein.   

Abstract

We studied the induction of antigen-specific IgA memory B cells (B(M)) in volunteers who received live attenuated Shigella flexneri 2a vaccines. Subjects ingested a single oral dose of 10(7), 10(8) or 10(9) CFU of S. flexneri 2a with deletions in guaBA (CVD 1204) or in guaBA, set and sen (CVD 1208). Antigen-specific serum and stool antibody responses to LPS and Ipa B were measured on days 0, 7, 14, 28 and 42. IgA B(M) cells specific to LPS, Ipa B and total IgA were assessed on days 0 and 28. We show the induction of significant LPS-specific IgA B(M) cells in anti-LPS IgA seroresponders. Positive correlations were found between anti-LPS IgA B(M) cells and anti-LPS IgA in serum and stool; IgA B(M) cell responses to IpaB were also observed. These B(M) cell responses are likely play an important role in modulating the magnitude and longevity of the humoral response.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21388888      PMCID: PMC3078965          DOI: 10.1016/j.clim.2011.02.003

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  43 in total

1.  Acute and long-term effects of booster immunisation on frequencies of antigen-specific memory B-lymphocytes.

Authors:  R Nanan; D Heinrich; M Frosch; H W Kreth
Journal:  Vaccine       Date:  2001-11-12       Impact factor: 3.641

2.  Production of IFN-gamma and IL-10 to Shigella invasins by mononuclear cells from volunteers orally inoculated with a Shiga toxin-deleted Shigella dysenteriae type 1 strain.

Authors:  T Samandari; K L Kotloff; G A Losonsky; W D Picking; P J Sansonetti; M M Levine; M B Sztein
Journal:  J Immunol       Date:  2000-02-15       Impact factor: 5.422

3.  Cutting edge: long-term B cell memory in humans after smallpox vaccination.

Authors:  Shane Crotty; Phil Felgner; Huw Davies; John Glidewell; Luis Villarreal; Rafi Ahmed
Journal:  J Immunol       Date:  2003-11-15       Impact factor: 5.422

4.  Tracking human antigen-specific memory B cells: a sensitive and generalized ELISPOT system.

Authors:  Shane Crotty; Rachael D Aubert; John Glidewell; Rafi Ahmed
Journal:  J Immunol Methods       Date:  2004-03       Impact factor: 2.303

5.  Live oral Shigella vaccine: vaccination schedule and the effect of booster dose.

Authors:  D M Mel; B L Arsic; M L Radovanovic; S A Litvinjenko
Journal:  Acta Microbiol Acad Sci Hung       Date:  1974

Review 6.  Chemistry and immunochemistry of bacterial lipopolysaccharides as cell wall antigens and endotoxins.

Authors:  O Westphal; K Jann; K Himmelspach
Journal:  Prog Allergy       Date:  1983

7.  Deletion in the Shigella enterotoxin genes further attenuates Shigella flexneri 2a bearing guanine auxotrophy in a phase 1 trial of CVD 1204 and CVD 1208.

Authors:  Karen L Kotloff; Marcela F Pasetti; Eileen M Barry; James P Nataro; Steven S Wasserman; Marcelo B Sztein; William D Picking; Myron M Levine
Journal:  J Infect Dis       Date:  2004-10-19       Impact factor: 5.226

8.  Studies on vaccination against bacillary dysentery. 6. Protection of children by oral immunization with streptomycin-dependent Shigella strains.

Authors:  D Mel; E J Gangarosa; M L Radovanovic; B L Arsic; S Litvinjenko
Journal:  Bull World Health Organ       Date:  1971       Impact factor: 9.408

9.  Maturation and trafficking markers on rotavirus-specific B cells during acute infection and convalescence in children.

Authors:  María C Jaimes; Olga L Rojas; Eric J Kunkel; Nicole H Lazarus; Dulce Soler; Eugene C Butcher; Dorsey Bass; Juana Angel; Manuel A Franco; Harry B Greenberg
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

Review 10.  Antimicrobial resistance among enteric pathogens.

Authors:  Larry K Pickering
Journal:  Semin Pediatr Infect Dis       Date:  2004-04
View more
  20 in total

1.  Insights from natural infection-derived immunity to cholera instruct vaccine efforts.

Authors:  Marcela F Pasetti; Myron M Levine
Journal:  Clin Vaccine Immunol       Date:  2012-09-19

Review 2.  Recent progress in mucosal vaccine development: potential and limitations.

Authors:  Nils Lycke
Journal:  Nat Rev Immunol       Date:  2012-07-25       Impact factor: 53.106

Review 3.  Progress and pitfalls in Shigella vaccine research.

Authors:  Eileen M Barry; Marcela F Pasetti; Marcelo B Sztein; Alessio Fasano; Karen L Kotloff; Myron M Levine
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-02-19       Impact factor: 46.802

Review 4.  Serum IgG antibodies to Shigella lipopolysaccharide antigens - a correlate of protection against shigellosis.

Authors:  Dani Cohen; Shiri Meron-Sudai; Anya Bialik; Valeria Asato; Sophy Goren; Ortal Ariel-Cohen; Arava Reizis; Amit Hochberg; Shai Ashkenazi
Journal:  Hum Vaccin Immunother       Date:  2019-05-09       Impact factor: 3.452

5.  Live oral typhoid vaccine Ty21a induces cross-reactive humoral immune responses against Salmonella enterica serovar Paratyphi A and S. Paratyphi B in humans.

Authors:  Rezwanul Wahid; Raphael Simon; Shah J Zafar; Myron M Levine; Marcelo B Sztein
Journal:  Clin Vaccine Immunol       Date:  2012-04-04

6.  Circulating Gut-Homing (α4β7+) Plasmablast Responses against Shigella Surface Protein Antigens among Hospitalized Patients with Diarrhea.

Authors:  Anuradha Sinha; Ayan Dey; Giulietta Saletti; Pradip Samanta; Partha Sarathi Chakraborty; M K Bhattacharya; Santanu Ghosh; T Ramamurthy; Jae-Ouk Kim; Jae Seung Yang; Dong Wook Kim; Cecil Czerkinsky; Ranjan K Nandy
Journal:  Clin Vaccine Immunol       Date:  2016-07-05

7.  Shigella antigen-specific B memory cells are associated with decreased disease severity in subjects challenged with wild-type Shigella flexneri 2a.

Authors:  Rezwanul Wahid; Jakub K Simon; Wendy L Picking; Karen L Kotloff; Myron M Levine; Marcelo B Sztein
Journal:  Clin Immunol       Date:  2013-03-26       Impact factor: 3.969

8.  Broadly protective Shigella vaccine based on type III secretion apparatus proteins.

Authors:  Francisco J Martinez-Becerra; Julian M Kissmann; Jovita Diaz-McNair; Shyamal P Choudhari; Amy M Quick; Gabriela Mellado-Sanchez; John D Clements; Marcela F Pasetti; Wendy L Picking
Journal:  Infect Immun       Date:  2011-12-27       Impact factor: 3.441

9.  Diverse phosphorylation patterns of B cell receptor-associated signaling in naïve and memory human B cells revealed by phosphoflow, a powerful technique to study signaling at the single cell level.

Authors:  Franklin R Toapanta; Paula J Bernal; Marcelo B Sztein
Journal:  Front Cell Infect Microbiol       Date:  2012-10-17       Impact factor: 5.293

10.  Applying mathematical tools to accelerate vaccine development: modeling Shigella immune dynamics.

Authors:  Courtney L Davis; Rezwanul Wahid; Franklin R Toapanta; Jakub K Simon; Marcelo B Sztein; Doron Levy
Journal:  PLoS One       Date:  2013-04-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.